{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T22:59:14Z","timestamp":1794869954884,"version":"4.9.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol J"],"published-print":{"date-parts":[[2011,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Mass <jats:italic>in ovo<\/jats:italic> vaccination with live attenuated viruses is widely used in the poultry industry to protect against various infectious diseases. The worldwide outbreaks of low pathogenic and highly pathogenic avian influenza highlight the pressing need for the development of similar mass vaccination strategies against avian influenza viruses. We have previously shown that a genetically modified live attenuated avian influenza virus (LAIV) was amenable for <jats:italic>in ovo<\/jats:italic> vaccination and provided optimal protection against H5 HPAI viruses. However, <jats:italic>in ovo<\/jats:italic> vaccination against other subtypes resulted in poor hatchability and, therefore, seemed impractical. In this study, we modified the H7 and H9 hemagglutinin (HA) proteins by substituting the amino acids at the cleavage site for those found in the H6 HA subtype. We found that with this modification, a single dose <jats:italic>in ovo<\/jats:italic> vaccination of 18-day old eggs provided complete protection against homologous challenge with low pathogenic virus in \u226570% of chickens at 2 or 6 weeks post-hatching. Further, inoculation of 19-day old egg embryos with 10<jats:sup>6<\/jats:sup> EID<jats:sub>50<\/jats:sub> of LAIVs improved hatchability to \u226590% (equivalent to unvaccinated controls) with similar levels of protection. Our findings indicate that the strategy of modifying the HA cleavage site combined with the LAIV backbone could be used for <jats:italic>in ovo<\/jats:italic> vaccination against avian influenza. Importantly, with protection conferred as early as 2 weeks post-hatching, with this strategy birds would be protected prior to or at the time of delivery to a farm or commercial operation.<\/jats:p>","DOI":"10.1186\/1743-422x-8-31","type":"journal-article","created":{"date-parts":[[2011,1,21]],"date-time":"2011-01-21T19:15:51Z","timestamp":1295637351000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Improved hatchability and efficient protection after in ovo vaccination with live-attenuated H7N2 and H9N2 avian influenza viruses"],"prefix":"10.1186","volume":"8","author":[{"given":"Yibin","family":"Cai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haichen","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianqiang","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongxia","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rangarajan","family":"Padmanabhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Troy C","family":"Sutton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel R","family":"Perez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,1,21]]},"reference":[{"key":"1148_CR1","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1111\/j.1600-065X.2008.00668.x","volume":"225","author":"DE Swayne","year":"2008","unstructured":"Swayne DE, Kapczynski D: Strategies and challenges for eliciting immunity against avian influenza virus in birds. Immunol Rev 2008, 225: 314-331. 10.1111\/j.1600-065X.2008.00668.x","journal-title":"Immunol Rev"},{"key":"1148_CR2","doi-asserted-by":"publisher","first-page":"9238","DOI":"10.1128\/JVI.00893-07","volume":"81","author":"H Song","year":"2007","unstructured":"Song H, Nieto GR, Perez DR: A new generation of modified live-attenuated avian influenza viruses using a two-strategy combination as potential vaccine candidates. J Virol 2007, 81: 9238-9248. 10.1128\/JVI.00893-07","journal-title":"J Virol"},{"key":"1148_CR3","doi-asserted-by":"publisher","first-page":"3320","DOI":"10.1016\/S0264-410X(01)00045-7","volume":"19","author":"MD Wareing","year":"2001","unstructured":"Wareing MD, Tannock GA: Live attenuated vaccines against influenza; an historical review. Vaccine 2001, 19: 3320-3330. 10.1016\/S0264-410X(01)00045-7","journal-title":"Vaccine"},{"key":"1148_CR4","doi-asserted-by":"publisher","first-page":"132","DOI":"10.2307\/1592516","volume":"44","author":"DE Swayne","year":"2000","unstructured":"Swayne DE, Beck JR, Kinney N: Failure of a recombinant fowl poxvirus vaccine containing an avian influenza hemagglutinin gene to provide consistent protection against influenza in chickens preimmunized with a fowl pox vaccine. Avian Dis 2000, 44: 132-137. 10.2307\/1592516","journal-title":"Avian Dis"},{"key":"1148_CR5","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1128\/JVI.01920-08","volume":"83","author":"J Steel","year":"2009","unstructured":"Steel J, Lowen AC, Pena L, Angel M, Solorzano A, Albrecht R, Perez DR, Garcia-Sastre A, Palese P: Live attenuated influenza viruses containing NS1 truncations as vaccine candidates against H5N1 highly pathogenic avian influenza. J Virol 2009, 83: 1742-1753. 10.1128\/JVI.01920-08","journal-title":"J Virol"},{"key":"1148_CR6","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.virol.2009.08.013","volume":"394","author":"OP Zhirnov","year":"2009","unstructured":"Zhirnov OP, Klenk HD: Alterations in caspase cleavage motifs of NP and M2 proteins attenuate virulence of a highly pathogenic avian influenza virus. Virology 2009, 394: 57-63. 10.1016\/j.virol.2009.08.013","journal-title":"Virology"},{"key":"1148_CR7","doi-asserted-by":"publisher","first-page":"8203","DOI":"10.1073\/pnas.0602566103","volume":"103","author":"MS Park","year":"2006","unstructured":"Park MS, Steel J, Garcia-Sastre A, Swayne D, Palese P: Engineered viral vaccine constructs with dual specificity: avian influenza and Newcastle disease. Proc Natl Acad Sci USA 2006, 103: 8203-8208. 10.1073\/pnas.0602566103","journal-title":"Proc Natl Acad Sci USA"},{"key":"1148_CR8","doi-asserted-by":"publisher","first-page":"4309","DOI":"10.1073\/pnas.070525997","volume":"97","author":"J Talon","year":"2000","unstructured":"Talon J, Salvatore M, O'Neill RE, Nakaya Y, Zheng H, Muster T, Garcia-Sastre A, Palese P: Influenza A and B viruses expressing altered NS1 proteins: A vaccine approach. Proc Natl Acad Sci USA 2000, 97: 4309-4314. 10.1073\/pnas.070525997","journal-title":"Proc Natl Acad Sci USA"},{"key":"1148_CR9","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/S0042-6822(02)00035-1","volume":"306","author":"H Jin","year":"2003","unstructured":"Jin H, Lu B, Zhou H, Ma C, Zhao J, Yang CF, Kemble G, Greenberg H: Multiple amino acid residues confer temperature sensitivity to human influenza virus vaccine strains (FluMist) derived from cold-adapted A\/Ann Arbor\/6\/60. Virology 2003, 306: 18-24. 10.1016\/S0042-6822(02)00035-1","journal-title":"Virology"},{"key":"1148_CR10","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1016\/j.vaccine.2007.11.032","volume":"26","author":"J Steel","year":"2008","unstructured":"Steel J, Burmakina SV, Thomas C, Spackman E, Garcia-Sastre A, Swayne DE, Palese P: A combination in-ovo vaccine for avian influenza virus and Newcastle disease virus. Vaccine 2008, 26: 522-531. 10.1016\/j.vaccine.2007.11.032","journal-title":"Vaccine"},{"key":"1148_CR11","doi-asserted-by":"publisher","first-page":"2886","DOI":"10.1016\/j.vaccine.2006.09.047","volume":"25","author":"H Toro","year":"2007","unstructured":"Toro H, Tang DC, Suarez DL, Sylte MJ, Pfeiffer J, Van Kampen KR: Protective avian influenza in ovo vaccination with non-replicating human adenovirus vector. Vaccine 2007, 25: 2886-2891. 10.1016\/j.vaccine.2006.09.047","journal-title":"Vaccine"},{"key":"1148_CR12","doi-asserted-by":"publisher","first-page":"2682","DOI":"10.1099\/vir.0.2008\/004143-0","volume":"89","author":"D Hickman","year":"2008","unstructured":"Hickman D, Hossain MJ, Song H, Araya Y, Solorzano A, Perez DR: An avian live attenuated master backbone for potential use in epidemic and pandemic influenza vaccines. J Gen Virol 2008, 89: 2682-2690. 10.1099\/vir.0.2008\/004143-0","journal-title":"J Gen Virol"},{"key":"1148_CR13","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1080\/03079450701557149","volume":"36","author":"J Tan","year":"2007","unstructured":"Tan J, Cooke J, Clarke N, Tannock GA: Molecular evaluation of responses to vaccination and challenge by Marek's disease viruses. Avian Pathol 2007, 36: 351-359. 10.1080\/03079450701557149","journal-title":"Avian Pathol"},{"key":"1148_CR14","doi-asserted-by":"publisher","first-page":"570","DOI":"10.2307\/1590742","volume":"31","author":"JM Sharma","year":"1987","unstructured":"Sharma JM: Delayed replication of Marek's disease virus following in ovo inoculation during late stages of embryonal development. Avian Dis 1987, 31: 570-576. 10.2307\/1590742","journal-title":"Avian Dis"},{"key":"1148_CR15","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/S0065-3519(99)80037-8","volume":"41","author":"CA Ricks","year":"1999","unstructured":"Ricks CA, Avakian A, Bryan T, Gildersleeve R, Haddad E, Ilich R, King S, Murray L, Phelps P, Poston R, et al.: In ovo vaccination technology. Adv Vet Med 1999, 41: 495-515. full_text","journal-title":"Adv Vet Med"},{"key":"1148_CR16","doi-asserted-by":"crossref","unstructured":"Williams CJ, Zedek AS: Comparative field evaluations of in ovo applied technology. Poult Sci 89: 189-193. 10.3382\/ps.2009-00093","DOI":"10.3382\/ps.2009-00093"},{"key":"1148_CR17","first-page":"493","volume":"37","author":"LJ Reed","year":"1938","unstructured":"Reed LJ, Muench H: A simple method for estimating 50 percent endpoints. Am J Hyg 1938, 37: 493.","journal-title":"Am J Hyg"},{"key":"1148_CR18","unstructured":"WHO Manual on Animal Influenza Diagnosis and Surveillance[http:\/\/www.who.int\/csr\/resources\/publications\/influenza\/whocdscsrncs20025rev.pdf]"},{"key":"1148_CR19","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1016\/S0140-6736(04)15892-3","volume":"363","author":"RJ Webby","year":"2004","unstructured":"Webby RJ, Perez DR, Coleman JS, Guan Y, Knight JH, Govorkova EA, McClain-Moss LR, Peiris JS, Rehg JE, Tuomanen EI, Webster RG: Responsiveness to a pandemic alert: use of reverse genetics for rapid development of influenza vaccines. Lancet 2004, 363: 1099-1103. 10.1016\/S0140-6736(04)15892-3","journal-title":"Lancet"},{"key":"1148_CR20","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0378-1135(00)00160-7","volume":"74","author":"DJ Alexander","year":"2000","unstructured":"Alexander DJ: A review of avian influenza in different bird species. Vet Microbiol 2000, 74: 3-13. 10.1016\/S0378-1135(00)00160-7","journal-title":"Vet Microbiol"},{"key":"1148_CR21","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1111\/j.1863-2378.2007.01082.x","volume":"55","author":"DJ Alexander","year":"2008","unstructured":"Alexander DJ: Avian influenza - diagnosis. Zoonoses Public Health 2008, 55: 16-23. 10.1111\/j.1863-2378.2007.01082.x","journal-title":"Zoonoses Public Health"},{"key":"1148_CR22","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1017\/S1466252310000095","volume":"11","author":"DL Suarez","year":"2010","unstructured":"Suarez DL: Avian influenza: our current understanding. Anim Health Res Rev 2010, 11: 19-33. 10.1017\/S1466252310000095","journal-title":"Anim Health Res Rev"},{"key":"1148_CR23","first-page":"167","volume":"3","author":"H Kido","year":"2008","unstructured":"Kido H, Okumura Y, Takahashi E, Pan HY, Wang S, Chida J, Le TQ, Yano M: Host envelope glycoprotein processing proteases are indispensable for entry into human cells by seasonal and highly pathogenic avian influenza viruses. J Mol Genet Med 2008, 3: 167-175.","journal-title":"J Mol Genet Med"},{"key":"1148_CR24","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.virol.2006.06.003","volume":"353","author":"CW Lee","year":"2006","unstructured":"Lee CW, Lee YJ, Senne DA, Suarez DL: Pathogenic potential of North American H7N2 avian influenza virus: a mutagenesis study using reverse genetics. Virology 2006, 353: 388-395. 10.1016\/j.virol.2006.06.003","journal-title":"Virology"},{"key":"1148_CR25","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.cimid.2008.01.007","volume":"32","author":"CW Lee","year":"2009","unstructured":"Lee CW, Saif YM: Avian influenza virus. Comp Immunol Microbiol Infect Dis 2009, 32: 301-310. 10.1016\/j.cimid.2008.01.007","journal-title":"Comp Immunol Microbiol Infect Dis"},{"key":"1148_CR26","doi-asserted-by":"publisher","first-page":"189","DOI":"10.3382\/ps.2009-00093","volume":"89","author":"CJ Williams","year":"2010","unstructured":"Williams CJ, Zedek AS: Comparative field evaluations of in ovo applied technology. Poult Sci 2010, 89: 189-93. 10.3382\/ps.2009-00093","journal-title":"Poult Sci"},{"key":"1148_CR27","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1080\/01652176.2004.9695170","volume":"26","author":"T Negash","year":"2004","unstructured":"Negash T, al-Garib SO, Gruys E: Comparison of in ovo and post-hatch vaccination with particular reference to infectious bursal disease. A review. Vet Q 2004, 26: 76-87.","journal-title":"Vet Q"}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1743-422X-8-31.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T06:30:56Z","timestamp":1630477856000},"score":1,"resource":{"primary":{"URL":"https:\/\/virologyj.biomedcentral.com\/articles\/10.1186\/1743-422X-8-31"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1,21]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["1148"],"URL":"https:\/\/doi.org\/10.1186\/1743-422x-8-31","relation":{},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,1,21]]},"assertion":[{"value":"12 October 2010","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2011","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2011","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"31"}}